Understand Resistant Hypertension with On-line Education

Understand Resistant Hypertension with On-line Education. On this MedNet21 CME Webcast, we’re going to hear more about resistant hypertension: what some of the causes are, what the pharmacologic approach is, and how a new endovascular procedure might hold the promise of improved blood pressure control for these patients in the future.  Let me welcome today’s guests in the studio with Dr. Jim Allen.  First, we have from the Division of Nephrology, Assistant Professor of Internal Medicine Dr. Christopher Valentine. Joining him from the Division of Cardiovascular Medicine is Associate Professor of Internal Medicine and the Medical Director of the Richard M. Ross Heart Hospital at the Wexner Medical Center, Dr. Ernest Mazzaferri.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW secondary causes of hypertension; Discuss therapy of resistant hypertension; and RECOGNIZE the Role of Sympathetic N.S. in HTN.

You’ll also learn about the following:

• Epidemiology of resistant hypertension
• Consequences of inadequately treated hypertension
• The future of catheter-based renal denervation
• Patient selection for renal denervation
• An On-line Webcast about Secondary Causes of Hypertension
• Lab testing of patients with resistant hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Antibiotics Webcast Provides Timely Update

New antibiotics webcast provides timely update.  The latest generation of antibiotics offers new weapons in the endless battle against infection but it is up to us as physicians to know when to pull out these new antibiotics.  In the studio for this CME webcast with our Moderator Dr. Jim Allen is Dr. Kurt Stevenson.  He’ll tell us about some of the newest drugs available to treat resistant infections.  Dr. Stevenson is a Professor of Internal Medicine and Epidemiology at the Ohio State University and oversees the antimicrobial stewardship program at the Wexner Medical Center.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the importance of judicious use of Antibiotics; and UNDERSTAND utility of newer antibiotics

You’ll also learn about the following:

• The pipeline of new antibiotics
• Antimicrobial stewardship at the Ohio State University
• Nebulized colistin
• Judicious use of new antibiotics

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.